Results 51 to 60 of about 214 (128)
European Journal of Heart Failure, Volume 27, Issue 12, Page 2671-2690, December 2025.Main categories of harmful drugs in heart failure. CCB, calcium channel blocker; DPP4i, dipeptidyl peptidase‐4 inhibitor; HER2‐TT, human epidermal growth factor receptor 2‐targeted therapy; NSAID, non‐steroidal anti‐inflammatory drug; TKI, tyrosine kinase inhibitor; TZD, thiazolidinedione; VEGF Inh, vascular endothelial growth factor inhibitor.
Amr Abdin +16 more
wiley +1 more source
Minimally Symptomatic Severe Hyponatremia: Two Case Reports
Clinical Practice and Cases in Emergency MedicineIntroduction: Hyponatremia is a common and often vexing electrolyte abnormality seen in the emergency setting. The severity of a patient’s symptoms is often dictated by the acuity of hyponatremia development and degree of serum sodium deficit, with ...
Jordan Richardson +2 more
doaj +1 more source
The Concise Guide to PHARMACOLOGY 2025/26: Enzymes
British Journal of Pharmacology, Volume 182, Issue S1, Page S307-S403, December 2025.The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander +31 more
wiley +1 more source
The Journal of Clinical HypertensionHyponatremia is a crucial complication of therapy with thiazide diuretics. This study compares the epidemiological and biochemical profiles and hospital course of patients using hydrochlorothiazide (HCTZ), indapamide (INDA), and chlorthalidone (CTD ...
Josef Klhůfek +6 more
doaj +1 more source
Российский кардиологический журнал, 2019 Achievement of target blood pressure (BP) is one of the key strategies of primary prevention of cardiovascular complications in patients with arterial hypertension (AH). Aim.
Zh. D. Kobalava +3 more
doaj +1 more source
КардиоСоматика, 2015 The article discusses the problem of the use for the treatment of hypertension combination therapy. Advantages of application as a component of chlorthalidone therapy are discussed.
M. G Bubnova
doaj
The effect of chlorthalidone on cardiovascular and renal disease: A systematic review [PDF]
Journal of Research in Clinical MedicineIntroduction: Hypertension is a significant risk factor for cardiovascular disease (CVD), including coronary artery disease, cerebrovascular disease, peripheral artery disease, and arteriosclerosis.
Suryono Suryono +4 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 Background Prehypertension is associated with higher cardiovascular risk, target organ damage, and incidence of hypertension. The Prevention of Hypertension in Patients with PreHypertension (PREVER‐Prevention) trial aimed to evaluate the efficacy and ...
Sandra Costa Fuchs +31 more
doaj +1 more source
Compelling therapy of LVH: straight (and not-so-straight) inferences from evidence
Clinical Hypertension, 2019 We have read with interest the Korean Society of Hypertension guidelines for the management of hypertension and congratulate the Society for an extensive review of literature while drafting the guidelines. The guidelines indicate preferring ACE-I and CCB
Ravi Tejraj Mehta +2 more
doaj +1 more source
MODERN OPPORTUNITIES FOR ANTIHYPERTENSION THERAPY: THE PLACE OF AZILSARTAN MEDOXOMIL
Российский кардиологический журнал, 2017 Modern approaches to antihypertension therapy suppose the usage of combination drugs, making significant positive influence on the values of systemic blood pressure (BP) in daily and nocturnal periods, optimization of 24-hour BP profile, achieved target ...
V. V. Skibitsky, A. V. Fendrikova
doaj +1 more source